Field testing the CLEFT-Q
- Conditions
- Quality of LifePatient Reported Outcome MeasureCleft patients
- Registration Number
- NL-OMON24585
- Lead Sponsor
- niversity Medical Centre Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
* Children/adolescents with CL, CP, CLP between 6 and 29 years of age.
* Who gave written informed consent (and/or their parents in case of minors)
* who are under treatment in our centres or
* who had treatment in our centres in the past:
Exclusion Criteria
* Children with a cognitive disability and/or who cannot read.
* Children who do not understand/speak Dutch.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Outcome of the study: An internationally validated PROM for use by patients with cleft lip and/or palate.
- Secondary Outcome Measures
Name Time Method not applicable
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does the CLEFT-Q assess psychosocial and functional domains in cleft lip and palate patients compared to existing PRO instruments?
What biomarkers correlate with long-term quality of life outcomes in cleft patients using the CLEFT-Q as a primary endpoint?
How effective is the CLEFT-Q in evaluating treatment success in cleft palate repair versus standard-of-care PRO assessments?
What adverse psychosocial effects are identified through the CLEFT-Q in cleft patients, and how are they managed in clinical settings?
Are there alternative PRO tools for cleft lip and palate that offer better reliability or validity in multidisciplinary treatment evaluations?